With more than 100 tumor samples from 92 women with ovarian cancer, researchers searched for mutations related to treatment resistance and relapse.
The firm, launched last September, said in an SEC document that it is targeting $5 million in the financing round.
Researchers involved with the WGS500 study reported on findings from more than 150 clinical cases assessed by whole-genome sequencing.
The partners will sequence genes known to affect drug metabolism and response to create electronic medical record alerts and find clinically relevant gene variants.
Quest has been offering the test since April 13 through its Quest Diagnostics Nichols Institute in San Juan Capistrano, California.
In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.
Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.
A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.
The White House says ethical discussions about genome editing of the human germline are needed.